Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,281,977 papers from all fields of science
Search
Sign In
Create Free Account
bazedoxifene
Known as:
1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-
, bazedoxifene/conjugated estrogens
An indole derivative and third-generation selective estrogen receptor modulator (SERM) with potential antineoplastic activity. Upon administration…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Broader (3)
Bone Density Conservation Agents
Indoles
Selective Estrogen Receptor Modulators
Narrower (3)
Duavee
TSE 424
WAY-140424
NCIt Antineoplastic Agent Terminology
bazedoxifene / Estrogens, Conjugated (USP)
bazedoxifene acetate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Conjugated oestrogens/bazedoxifene.
Australian Prescriber
2017
Corpus ID: 35531361
In longer term trials (12–24 months), the 0.45 mg/20 mg dose did not appear to significantly increase bleeding events (including…
Expand
2016
2016
Duavive HRT: conjugated oestrogens with bazedoxifene
S. Chaplin
2016
Corpus ID: 78720062
Duavive is a new oral HRT formulation containing conjugated oestrogens and the selective oestrogen‐receptor modulator…
Expand
2015
2015
Duavee: a tissue-selective estrogen complex for menopausal symptoms and prevention of osteoporosis
D. Tikoo
,
Meenakshi Gupta
2015
Corpus ID: 56632536
Post-menopausal women suffer from a plethora of problems like vasomotor symptoms, vulvovaginal atrophy (VVA), bone loss, and all…
Expand
2013
2013
Novel Small Molecules Disabling the IL-6/IL-6R/GP130 Heterohexamer Complex
Chenglong Li
,
J. Fuchs
,
Jiayuh Lin
2013
Corpus ID: 51748206
Abstract : Interleukin-6 (IL-6) is a key signaling molecule in breast cancer cells. It is responsible for many cellular responses…
Expand
Review
2013
Review
2013
Hormonal and Non-Hormonal Management of Vasomotor Symptoms: A Narrated Review
O. Tan
,
A. Pinto
,
B. Carr
2013
Corpus ID: 44207917
Background: Vasomotor symptoms (VMS; hot flashes, hot flushes) are the most common complaints of peri- and postmenopausal women…
Expand
2013
2013
THE ROLE OF SELECTİVE ESTROGEN MODULATOR BAZEDOXIFENE IN THE TREATMENT OF ENDOMETRIOSIS IN A RAT MODEL
S. Mine
,
H. C. Gülerman
,
Özlem Moraloğlu
,
O. Uzunlar
,
A. Aktulay
,
Zekai Tahir
2013
Corpus ID: 88030447
Amaç: Endometriozisin gelişiminde rol aldığı kesin olarak gösterilmiş tek faktör östrojendir. Bu çalışmanın amacı; ratlarda…
Expand
2011
2011
Bazedoxifene: An investigational selective estrogen receptor modulator for the treatment and prevention of osteoporosis in postmenopausal women
D. Sobieraj
,
Pharmd
,
Bcps
2011
Corpus ID: 73328279
A new selective estrogen receptor modulator, bazedoxifene acetate, is currently under development in an effort to maximize…
Expand
2010
2010
Efficacy of bazedoxifene, pre-biphosphonate sequential therapy for osteoporosis and the patient profile for bazedoxifene
S. PalaciosGil-Antuñano
,
A. Acuña
2010
Corpus ID: 55222024
Summary Osteoporosis is a gendered disease, being especially prevalent in postmenopausal women due to the sharp drop in levels of…
Expand
Review
2009
Review
2009
New therapies for osteoporosis: Zoledronic acid, bazedoxifene, and denosumab
S. Silverman
Current Osteoporosis Reports
2009
Corpus ID: 37693958
Intravenous (IV) zoledronic acid, a new once-yearly bisphosphonate therapy, is approved by the US Food and Drug Administration…
Expand
2005
2005
Polymorphe cristallin d'acetate de bazedoxifene
K. Ali
,
P. Allegrini
,
+8 authors
Massimo Verzini
2005
Corpus ID: 103825552
La presente invention concerne un polymorphe cristallin d'acetate de bazedoxifene, des compositions qui le contiennent, des…
Expand